Prof. Dieter Willbold participated at the DGN Kongress in Stuttgart.He gave a talk on the 26^th September at 09.10 am.

Content: Targeting Alzheimer´s disease with the first anti-prionic compound: PRI-002 proved safey and tolerability in Phase-I-studies.